Skip to content

Opioid Reduction Program for Total Knee Replacement Patients

Opioid Reduction Program for Total Knee Replacement Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05414942
Acronym
TKR ORP
Enrollment
85
Registered
2022-06-10
Start date
2021-08-01
Completion date
2022-05-25
Last updated
2022-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Injuries, Knee Injuries and Disorders, Opioid Use

Keywords

Opioid, Total Knee Replacement, Knee Arthroplasty, Knee Injuries, Prevention, Analgesics, Opioid

Brief summary

In the context of prescribed opioids, research suggests that increased exposure is associated with long-term opioid use. Orthopedic surgeries are associated with the prescribing of more opioid narcotics than any other surgical specialty, particularly for Total Knee Replacement surgery, which is associated with severe post-operative pain. The proposed project is a randomized clinical trial to explore the efficacy of our Total Knee Replacement Opioid Reduction Program (ORP) vs. Treatment As Usual (TAU) in the reduction of opioid use following total knee replacement surgery.

Detailed description

The purpose of the study is to build upon our existing research to: (1) explore the efficacy of a disseminable Opioid Reduction Program (ORP) to reduce long-term use of prescribed opioids following TKR surgery, (2) assess whether lower opioid use following surgery is related to better functional recovery, and (3) model opioid use trajectories following TKR surgery (i.e., MMEs/week for 12 weeks), which will allow us to examine the factors that characterize at-risk groups. There will be one control arm (Treatment as Usual or TAU) and one experimental arm (Opioid Reduction Program or ORP). The experimental arm will receive the intervention material twice. The first session is pre-surgery, and the second session is a shortened booster session approximately 2-weeks post-op.

Interventions

BEHAVIORALOpioid Reduction Program

Subjects will engage in a brief, educational session which includes information about the appropriate use of opioid pain medication, exposure and tolerance, the definition of misuse and opioid-related harms, how to wean off medication, alternative pain management strategies, and appropriate disposal of leftover medication.

Sponsors

Campbell Clinic
CollaboratorOTHER
University of Tennessee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older. * Presenting for a total knee replacement (TKR) surgery at Campbell Clinic which will result in an opioid prescription. * Access to a telephone. * Able to consent in English.

Exclusion criteria

* Under the age of 18. * Contraindications to use of opioid medication. * No access to a telephone. * Unable to understand consent materials in English.

Design outcomes

Primary

MeasureTime frameDescription
Opioid pills (dose and type) prescribed by Campbell Clinic.12-weeks post-op.transcribed from medical record at Campbell Clinic
Opioid pills prescribed outside of Campbell Clinic.12-weeks post-op.assessed via scan of prescription drug monitoring database for Tennessee
Opioid pill count questionnaire.12-weeks post-op.self-report from participant of how many opioids are left in the bottle at the 12 week assessment

Secondary

MeasureTime frameDescription
KOOS Jr.12-weeks post-op.There are 3 domains scored from the 7-item measure: Stiffness (1 item), assessed on a 1-5 scale from None to Extreme; Pain (4 items), assessed on a 1-5 scale from None to Extreme; Function, daily living (2 items), assessed on a 1-5 scale from None to Extreme

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026